News From Trenton · January 28, 2025
HealthCare Institute of New Jersey submits comments on PDAC Special Rule Adoption
Trenton, January 21, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning comments HINJ submitted to the NJ Division of Consumer Affairs' concerning its proposed rules currently in effect and being considered for formal adoption relating to prescription drug price transparency and the New Jersey Prescription Drug Affordability Council:
“Lowering health care costs is a universally shared goal. There are smart and efficient ideas that can immediately lower costs for patients without jeopardizing New Jersey’s global leadership in medical innovation or harming New Jersey’s 369,000 life sciences jobs or this $130 billion segment of our state’s economy.
From NJ SEED: News From Trenton - January 28, 2025.